Business
Izotropic Prepares New Platforms to Educate and Engage
- Strategic awareness initiatives underway ahead of IzoView commercialization -- Company podcast and breasct.com website in development to expand engagement -- Market-facing activities aligned with investor communications and corporate milestones -Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - July 15, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utiliz
About this update from Izotropic Corp.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":1,"height":1,"url":"https://api.newsfilecorp.com/newsinfo/258830/202"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/al.Hv0caBqotRC1sXiZ5Lw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2O2g9MzY7Y2Y9d2VicA--/https://api.newsfilecorp.com/newsinfo/258830/202","width":1,"height":1}},"lazy":false},{"type":"text","content":"- Strategic awareness initiatives underway ahead of IzoView commercialization -- Company podcast and breasct.com website in development to expand engagement -- Market-facing activities aligned with investor communications and corporate milestones -","length":250,"tagName":"p","attribs":{}},{"type":"text","content":"Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - July 15, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it is initiating strategic awareness plans in anticipation of the future commercialization of its breakthrough device, the IzoView Breast CT Imaging System.","length":566,"tagName":"p"},{"type":"text","content":"Izotropic's awareness efforts will center on a consistent and compelling stream of development-related news to educate global audiences on the transformative value of dedicated breast CT technology. These initiatives will spotlight how IzoView stands apart from traditional breast imaging modalities and competing breast CT systems, positioning it as a true game-changer in the field. The campaign will emphasize IzoView's unique, proprietary features including patented hardware innovations, trade-secret software elements, and next-generation AI integrations, to reinforce the device's competitive edge and accelerate market adoption. Emerging breast imaging trends, evolving regulatory frameworks, and robust market growth forecasts will be incorporated to contextualize IzoView's potential. The Company's narrative will be refined, data-driven, and strategically repackaged to engage new audiences and support its commercialization and go-to-market initiatives.","length":985,"tagN...